Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Mabpharm Limited per 2025 Jun 30 adalah 423.93 MM.
- Nilai operating income untuk Mabpharm Limited per 2025 Jun 30 adalah -23.87 MM.
- Nilai net income untuk Mabpharm Limited per 2025 Jun 30 adalah -27.48 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 423.93 | -23.87 | -27.48 |
2025-03-31 | 341.08 | -71.77 | -77.71 |
2024-12-31 | 258.23 | -119.67 | -127.95 |
2024-09-30 | 204.93 | -159.03 | -167.44 |
2024-06-30 | 151.62 | -198.38 | -206.93 |
2024-03-31 | 119.39 | -200.18 | -208.14 |
2023-12-31 | 87.16 | -201.98 | -209.36 |
2023-09-30 | 79.13 | -200.74 | -201.68 |
2023-06-30 | 71.09 | -199.50 | -194.01 |
2023-03-31 | 63.50 | -212.88 | -202.41 |
2022-12-31 | 55.92 | -226.25 | -210.82 |
2022-09-30 | 43.20 | -252.17 | -237.11 |
2022-06-30 | 30.48 | -278.08 | -263.39 |
2022-03-31 | 56.68 | -287.80 | -277.57 |
2021-12-31 | 82.88 | -297.52 | -291.74 |
2021-09-30 | 82.06 | -267.45 | -283.67 |
2021-06-30 | 81.25 | -237.38 | -275.61 |
2021-03-31 | 40.62 | -211.79 | -230.12 |
2020-12-31 | -186.21 | -184.63 | |
2020-09-30 | 5.27 | -190.97 | -162.83 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | -0.05 | -0.05 |
2024-03-31 | -0.05 | -0.05 |
2023-12-31 | -0.05 | -0.05 |
2023-09-30 | -0.05 | -0.04 |
2023-06-30 | -0.05 | -0.04 |
2023-03-31 | -0.05 | -0.04 |
2022-12-31 | -0.05 | -0.05 |
2022-09-30 | -0.06 | -0.06 |
2022-06-30 | -0.06 | -0.06 |
2022-03-31 | -0.07 | -0.06 |
2021-12-31 | -0.07 | -0.07 |
2021-09-30 | -0.07 | -0.07 |
2021-06-30 | -0.07 | -0.07 |
2021-03-31 | -0.06 | -0.06 |
2020-12-31 | -0.04 | -0.04 |
2020-09-30 | -0.04 | -0.04 |
2020-06-30 | -0.03 | -0.03 |
2020-03-31 | -0.04 | -0.04 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Mabpharm Limited per 2025 Jun 30 adalah 103.11 MM.
- Nilai cash from investing activities untuk Mabpharm Limited per 2025 Jun 30 adalah -110.67 MM.
- Nilai kas dari aktivitas pendanaan untuk Mabpharm Limited per 2025 Jun 30 adalah 27.63 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 103.11 | -110.67 | 27.63 |
2025-03-31 | 49.50 | -104.43 | 22.96 |
2024-12-31 | -4.10 | -98.20 | 18.28 |
2024-09-30 | 11.33 | -61.01 | 32.85 |
2024-06-30 | 26.75 | -23.82 | 47.42 |
2024-03-31 | 42.07 | -13.66 | 66.51 |
2023-12-31 | 57.39 | -3.50 | 85.60 |
2023-09-30 | -10.99 | -18.69 | 70.11 |
2023-06-30 | -79.37 | -33.87 | 54.62 |
2023-03-31 | -68.13 | -69.41 | 83.44 |
2022-12-31 | -56.88 | -104.95 | 112.26 |
2022-09-30 | -79.51 | -143.65 | 85.99 |
2022-06-30 | -102.14 | -182.34 | 59.72 |
2022-03-31 | -150.80 | -180.88 | 20.97 |
2021-12-31 | -199.47 | -179.42 | -17.78 |
2021-09-30 | -185.00 | -141.98 | -14.54 |
2021-06-30 | -170.52 | -104.53 | -11.31 |
2021-03-31 | -158.88 | 25.73 | -45.89 |
2020-12-31 | -147.23 | 156.00 | -80.48 |
2020-09-30 | -146.69 | 15.66 | -103.06 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.14.
- roic untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.32.
- croic untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.21.
- ocroic untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.01.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.14 | -0.32 | -0.21 | -0.01 | |
2025-03-31 | -0.14 | -0.32 | 0.00 | 0.00 | |
2024-12-31 | -0.20 | -0.62 | -0.54 | 0.13 | 0.07 |
2024-09-30 | -0.20 | -0.82 | -0.54 | 0.13 | 0.07 |
2024-06-30 | -0.23 | -0.68 | -0.43 | 0.29 | 0.12 |
2024-03-31 | -0.23 | -0.52 | -0.43 | 0.29 | 0.12 |
2023-12-31 | -0.21 | -0.50 | -0.40 | 0.08 | -0.02 |
2023-09-30 | -0.21 | -0.40 | -0.39 | -0.11 | -0.16 |
2023-06-30 | -0.22 | -0.40 | -0.41 | -0.12 | -0.17 |
2023-03-31 | -0.22 | -0.41 | -0.43 | -0.11 | -0.14 |
2022-12-31 | -0.29 | -0.39 | -0.45 | -0.26 | -0.15 |
2022-09-30 | -0.29 | -0.39 | -0.45 | -0.26 | -0.15 |
2022-06-30 | -0.30 | -0.35 | -0.49 | -0.42 | -0.19 |
2022-03-31 | -0.30 | -0.37 | -0.52 | -0.59 | -0.28 |
2021-12-31 | -0.24 | -0.33 | -0.45 | -0.62 | -0.22 |
2021-09-30 | -0.24 | -0.32 | -0.44 | -0.57 | -0.22 |
2021-06-30 | -0.21 | -0.27 | -0.35 | -0.43 | -0.22 |
2021-03-31 | -0.17 | -0.23 | -0.29 | -0.28 | -0.20 |
2020-12-31 | -0.13 | -0.18 | -0.20 | -0.11 | -0.16 |
2020-09-30 | -0.12 | -0.15 | -0.18 | -0.25 | -0.17 |
2020-06-30 | -0.10 | -0.12 | -0.13 | -0.35 | -0.13 |
2020-03-31 | -0.12 | -0.15 | -0.16 | 0.01 | -0.13 |
Gross Margins
- marjin kotor untuk Mabpharm Limited pada 2025 Jun 30 adalah 0.85.
- marjin bersih untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.50.
- marjin operasi untuk Mabpharm Limited pada 2025 Jun 30 adalah -0.46.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.85 | -0.50 | -0.46 |
2025-03-31 | 0.85 | -0.50 | -0.46 |
2024-12-31 | 0.87 | -1.36 | -1.31 |
2024-09-30 | 0.87 | -1.36 | -1.31 |
2024-06-30 | 0.86 | -2.40 | -2.32 |
2024-03-31 | 0.86 | -2.40 | -2.32 |
2023-12-31 | 0.85 | -2.73 | -2.81 |
2023-09-30 | 0.85 | -2.73 | -2.81 |
2023-06-30 | 0.73 | -2.73 | -2.81 |
2023-03-31 | 0.73 | -3.19 | -3.35 |
2022-12-31 | 0.64 | -5.49 | -5.84 |
2022-09-30 | 0.64 | -5.49 | -5.84 |
2022-06-30 | 0.80 | -8.64 | -9.12 |
2022-03-31 | 0.80 | -4.90 | -5.08 |
2021-12-31 | 0.84 | -3.52 | -3.59 |
2021-09-30 | 0.84 | -2.84 | -2.50 |
2021-06-30 | 0.84 | -2.65 | -2.06 |
2021-03-31 | 0.87 | -3.63 | -2.98 |
2020-12-31 | 1.00 | -8.11 | -8.17 |
2020-09-30 | 1.00 | -15.85 | -18.10 |
2020-06-30 | 1.00 | -6.05 | -7.85 |
2020-03-31 | 1.00 | -9.19 | -9.90 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |